Literature DB >> 34718810

Ozone Responsive Gene Expression as a Model for Describing Repeat Exposure Response Trajectories and Interindividual Toxicodynamic Variability In Vitro.

Emma C Bowers1, Elizabeth M Martin2,3, Annie M Jarabek4, David S Morgan5, Hannah J Smith6, Lisa A Dailey5, Emily R Aungst5, David Diaz-Sanchez5, Shaun D McCullough5.   

Abstract

Inhaled chemical/material exposures are a ubiquitous part of daily life around the world. There is a need to evaluate potential adverse effects of both single and repeat exposures for thousands of chemicals and an exponentially larger number of exposure scenarios (eg, repeated exposures). Meeting this challenge will require the development and use of in vitro new approach methodologies (NAMs); however, 2 major challenges face the deployment of NAMs in risk assessment are (1) characterizing what apical outcome(s) acute assays inform regarding the trajectory to long-term events, especially under repeated exposure conditions, and (2) capturing interindividual variability as it informs considerations of potentially susceptible and/or vulnerable populations. To address these questions, we used a primary human bronchial epithelial cell air-liquid interface model exposed to ozone (O3), a model oxidant and ubiquitous environmental chemical. Here we report that O3-induced proinflammatory gene induction is attenuated in repeated exposures thus demonstrating that single acute exposure outcomes do not reliably represent the trajectory of responses after repeated or chronic exposures. Further, we observed 10.1-, 10.3-, 14.2-, and 7-fold ranges of induction of interleukin (IL)-8, IL-6, heme oxygenase 1, and cyclooxygenase 2 transcripts, respectively, within in our population of 25 unique donors. Calculation of sample size estimates that indicated that 27, 24, 299, and 13 donors would be required to significantly power similar in vitro studies to identify a 2-fold change in IL-8, IL-6, HMOX1, and cyclooxygenase 2 transcript induction, respectively, to inform considerations of the uncertainty factors to reflect variability within the human population for in vitro studies. Published by Oxford University Press on behalf of the Society of Toxicology 2021. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  zzm321990 in vitro to in vivo extrapolation; air-liquid interface (ALI); inhalation risk assessment; interindividual variability; new approach methods (NAMs); ozone

Mesh:

Substances:

Year:  2021        PMID: 34718810      PMCID: PMC8714356          DOI: 10.1093/toxsci/kfab128

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  44 in total

1.  The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies.

Authors:  R A Jörres; O Holz; W Zachgo; P Timm; S Koschyk; B Müller; F Grimminger; W Seeger; F J Kelly; C Dunster; T Frischer; G Lubec; M Waschewski; A Niendorf; H Magnussen
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

2.  Exposure Effects Beyond the Epithelial Barrier: Transepithelial Induction of Oxidative Stress by Diesel Exhaust Particulates in Lung Fibroblasts in an Organotypic Human Airway Model.

Authors:  Samantha C Faber; Nicole A McNabb; Pablo Ariel; Emily R Aungst; Shaun D McCullough
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

3.  Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure.

Authors:  R B Devlin; W F McDonnell; S Becker; M C Madden; M P McGee; R Perez; G Hatch; D E House; H S Koren
Journal:  Toxicol Appl Pharmacol       Date:  1996-05       Impact factor: 4.219

4.  Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms.

Authors:  Nicole C Kleinstreuer; Jian Yang; Ellen L Berg; Thomas B Knudsen; Ann M Richard; Matthew T Martin; David M Reif; Richard S Judson; Mark Polokoff; David J Dix; Robert J Kavlock; Keith A Houck
Journal:  Nat Biotechnol       Date:  2014-05-18       Impact factor: 54.908

Review 5.  How many transcription factors does it take to turn on the heme oxygenase-1 gene?

Authors:  Jawed Alam; Julia L Cook
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-21       Impact factor: 6.914

6.  Effect of ozone and nitrogen dioxide on the permeability of bronchial epithelial cell cultures of non-asthmatic and asthmatic subjects.

Authors:  H Bayram; C Rusznak; O A Khair; R J Sapsford; M M Abdelaziz
Journal:  Clin Exp Allergy       Date:  2002-09       Impact factor: 5.018

7.  Induction of interleukin-8 by ozone is mediated by tyrosine kinase and protein kinase A, but not by protein kinase C.

Authors:  I Jaspers; L C Chen; E Flescher
Journal:  J Cell Physiol       Date:  1998-11       Impact factor: 6.384

8.  Considerations for Strategic Use of High-Throughput Transcriptomics Chemical Screening Data in Regulatory Decisions.

Authors:  Joshua Harrill; Imran Shah; R Woodrow Setzer; Derik Haggard; Scott Auerbach; Richard Judson; Russell S Thomas
Journal:  Curr Opin Toxicol       Date:  2019

9.  A human population-based organotypic in vitro model for cardiotoxicity screening.

Authors:  Fabian A Grimm; Alexander Blanchette; John S House; Kyle Ferguson; Nan-Hung Hsieh; Chimeddulam Dalaijamts; Alec A Wright; Blake Anson; Fred A Wright; Weihsueh A Chiu; Ivan Rusyn
Journal:  ALTEX       Date:  2018-07-08       Impact factor: 6.043

10.  The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.

Authors:  Christina Jessen; Julia K C Kreß; Apoorva Baluapuri; Anita Hufnagel; Werner Schmitz; Susanne Kneitz; Sabine Roth; André Marquardt; Silke Appenzeller; Carsten P Ade; Valerie Glutsch; Marion Wobser; José Pedro Friedmann-Angeli; Laura Mosteo; Colin R Goding; Bastian Schilling; Eva Geissinger; Elmar Wolf; Svenja Meierjohann
Journal:  Oncogene       Date:  2020-09-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.